Clinical Applications and Safety Profile of Remimazolam
Stay ahead of emerging pharmacology with an in-depth look at remimazolam—an ultra-short-acting benzodiazepine reshaping sedation and anesthesia care. This content explores its clinical applications, safety advantages, and hemodynamic benefits compared to agents like midazolam and propofol. Gain the knowledge you need to confidently integrate remimazolam into practice—especially for high-risk patients where stability and rapid recovery matter most.
Credit information
1.5 Class A
1.5 Pharmacology
Checking access...
Choose Your Purchase Option
Single Module
Purchase this module only
$24.99/one-time
9 Lessons
1.5 Class A (MAC-ed) credits
1.5 Pharmacology Hours
Auto CE tracking & certificates
Automatically submitted to the AANA
Optional $100 Completion Gift Card upgrade
Lifetime access to module materials
This module can be taken until December 31, 2027
Best Value
$449/yearly
Everything in Clinical Access Pro, plus
100+ CE modules
150+ Pre-approved Class A (MAC-ed) credits
Auto CE tracking & certificates
Automatically submitted to the AANA
$100 Completion Gift Card optional per module
Priority app support
100% money-back guarantee
Edition 2025
Purchase this full course
$99/one-time
This module + 3 more
6.0 Class A (MAC-ed) credits
6.0 Pharmacology hours
Auto CE tracking & certificates
Automatically submitted to the AANA
$100 Completion Gift Card optional per module
Lifetime access to course materials
This course can be taken until December 31, 2027
Module Content
Clinical Applications and Safety Profile of Remimazolam
Introduction
Clinical Applications of Remimazolam
Abuse Potential of Remimazolam
Safety Profile
Considerations in Pregnancy and Breastfeeding
Conclusion
Clinical Applications and Safety QuizQuiz
Clinical Applications and Safety Quiz (2nd Attempt)Quiz
Clinical Applications and Safety Quiz (3rd Attempt)Quiz
Course Details
- Self-paced
- English
- Certificate of Completion
- Take course anywhere or anytime
Pre-approved Credits
1.5 Class A
1.5 Pharmacology/Therapeutics